Growth Metrics

BioNTech SE (BNTX) Gains from Investment Securities (2018 - 2025)

BioNTech SE's Gains from Investment Securities history spans 8 years, with the latest figure at -$931234.8 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 771.46% to -$931234.8 in Q4 2025 year-over-year; TTM through Dec 2025 was -$15.4 million, a 164.39% decrease, with the full-year FY2025 number at -$2.8 million, down 781.07% from a year prior.
  • Gains from Investment Securities hit -$931234.8 in Q4 2025 for BioNTech SE, up from -$1.5 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for BNTX hit a ceiling of $24.2 million in Q1 2024 and a floor of -$1.4 billion in Q1 2022.
  • Historically, Gains from Investment Securities has averaged -$301.6 million across 5 years, with a median of -$1.1 million in 2025.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 212094123.02% in 2021 and later crashed 1200275504607.64% in 2022.
  • Tracing BNTX's Gains from Investment Securities over 5 years: stood at $4.8 million in 2021, then plummeted by 29560.69% to -$1.4 billion in 2022, then skyrocketed by 95.05% to -$70.0 million in 2023, then surged by 99.85% to -$106859.5 in 2024, then tumbled by 771.46% to -$931234.8 in 2025.
  • Business Quant data shows Gains from Investment Securities for BNTX at -$931234.8 in Q4 2025, -$1.5 million in Q3 2025, and -$12.8 million in Q1 2025.